Letter to the Standing Committee on Industry, Science and Technology re: Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act

“I write to follow up on our previous submissions to the Standing Committee regarding Bill C-9, Canada’s laudable initiative to implement the WTO General Council Decision of August 30, 2003 to enable countries lacking sufficient pharmaceutical manufacturing capacity to ‘make effective use’ of compulsory licensing to obtain lower cost generic pharmaceutical products manufactured in Canada…”

Download